Search by Drug Name or NDC

    NDC 61269-0981-35 DOCOSANOL 100 mg/g Details

    DOCOSANOL 100 mg/g

    DOCOSANOL is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by H2-Pharma, LLC. The primary component is DOCOSANOL.

    Product Information

    NDC 61269-0981
    Product ID 61269-981_8cde6b29-52f7-463f-9914-0b93771d87c7
    Associated GPIs 90350022003720
    GCN Sequence Number 047524
    GCN Sequence Number Description docosanol CREAM (G) 10 % TOPICAL
    HIC3 Q5V
    HIC3 Description TOPICAL ANTIVIRALS
    GCN 12866
    HICL Sequence Number 021956
    HICL Sequence Number Description DOCOSANOL
    Brand/Generic Generic
    Proprietary Name DOCOSANOL
    Proprietary Name Suffix n/a
    Non-Proprietary Name DOCOSANOL
    Product Type HUMAN OTC DRUG
    Dosage Form CREAM
    Route TOPICAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/g
    Substance Name DOCOSANOL
    Labeler Name H2-Pharma, LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208754
    Listing Certified Through 2024-12-31

    Package

    NDC 61269-0981-35 (61269098135)

    NDC Package Code 61269-981-35
    Billing NDC 61269098135
    Package 1 TUBE in 1 PACKAGE (61269-981-35) / 2 g in 1 TUBE
    Marketing Start Date 2021-06-29
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 5.94619
    Pricing Unit GM
    Effective Date 2024-02-21
    NDC Description DOCOSANOL 10% CREAM
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis
    << 61269-0835-10 61269-0989-37 >>

    Contents